Ireland Cancer Center Landerbrook Health Center

Mayfield Heights, Ohio, United States
Medical clinic in Mayfield Heights, Ohio
5850 Landerbrook Dr, Mayfield Heights, OH 44124

About Ireland Cancer Center Landerbrook Health Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
SWOG Cancer Research Network
9
Bayer
2
Alliance for Clinical Trials in Oncology
1
ECOG-ACRIN Cancer Research Group
1
National Cancer Institute (NCI)
1
Total Rows: 5

Clinical Trials at Ireland Cancer Center Landerbrook Health Center


During the past decade, Ireland Cancer Center Landerbrook Health Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 12 clinical trials were completed, i.e. on average, 240% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 10 clinical trials were completed. i.e. 500% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100220000002200001100111166Started TrialsCompleted Trails201520162017201820192020202102468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma
2010-12-13
2019-12-02
Completed
289
Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers
2010-10-01
2014-03-01
Terminated
14
S1211 Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma
2012-11-01
2024-06-01
Active, not recruiting
142
Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer
2014-01-22
2023-08-31
Active, not recruiting
1,311
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
2014-06-16
2022-04-15
Completed
1,864
Lung-MAP: Durvalumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
2014-07-01
2020-09-01
Completed
116
Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches
2014-11-01
2019-11-01
Completed
31
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer
2014-09-01
2019-06-01
Completed
53

Rows per page:

1–14 of 14

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Ireland Cancer Center Landerbrook Health Center" #1 sponsor was "SWOG Cancer Research Network" with 9 trials, followed by "Bayer" with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "National Cancer Institute (NCI)" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Ireland Cancer Center Landerbrook Health Center" #1 collaborator was "National Cancer Institute (NCI)" with 11 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Biologics, Inc." with 1 trials as a collaborator and "Medivation, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.
Created with Highcharts 11.1.0Top Leading SponsorsSWOG Cancer ResearchNetwork: 9SWOG Cancer ResearchNetwork: 9Bayer: 2Bayer: 2Alliance for ClinicalTrials in Oncology: 1Alliance for ClinicalTrials in Oncology: 1ECOG-ACRIN CancerResearch Group: 1ECOG-ACRIN CancerResearch Group: 1National Cancer Institute (NCI): 1National Cancer Institute (NCI): 1

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 11National CancerInstitute (NCI): 11Astellas Pharma US, Inc.: 1Astellas Pharma US, Inc.: 1Biologics, Inc.: 1Biologics, Inc.: 1Medivation, Inc.: 1Medivation, Inc.: 1

Clinical Trials Conditions at Ireland Cancer Center Landerbrook Health Center


According to Clinical.Site data, the most researched conditions in "Ireland Cancer Center Landerbrook Health Center" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "ATM Gene Mutation" (1 trials), "ATR Gene Mutation" (1 trials) and "Adenocarcinoma of the Prostate" (1 trials). Many other conditions were trialed in "Ireland Cancer Center Landerbrook Health Center" in a lesser frequency.

Clinical Trials Intervention Types at Ireland Cancer Center Landerbrook Health Center


Most popular intervention types in "Ireland Cancer Center Landerbrook Health Center" are "Drug" (12 trials), "Other" (9 trials) and "Biological" (6 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (9 trials), "Docetaxel" (4 trials), "Durvalumab" (3 trials), "FGFR Inhibitor AZD4547" (2 trials) and "Ipilimumab" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Ireland Cancer Center Landerbrook Health Center


The vast majority of trials in "Ireland Cancer Center Landerbrook Health Center" are 11 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at Ireland Cancer Center Landerbrook Health Center


Currently, there are NaN active trials in "Ireland Cancer Center Landerbrook Health Center". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Ireland Cancer Center Landerbrook Health Center, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Ireland Cancer Center Landerbrook Health Center, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 10Phase 2: 10Phase 3: 6Phase 3: 6Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 9Completed: 9Active, not recruiting: 4Active, not recruiting: 4Terminated: 1Terminated: 1